Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Resilient Biotics, a US-based developer of microbiome-based treatments for respiratory infections in animals, has raised $7.1m in a series A round co-led by Berkeley Catalyst Fund, a venture unit aligned to University of California (UC) Berkeley, according to AgFunderNews. Fulcrum Global Capital co-led the round, which also included veterinary medicine producer Elanco Animal Health as well as Innovation in Motion and Viking Global Investors.
B Dot Medical, a Japan-based proton beam therapy developer, had raised a total of ¥700m…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
